Dalby RN[au] - Search Results

Year	Number of Results
1987	1
1988	1
1989	1
1991	2
1992	1
1993	3
1996	1
1997	1
1998	3
2000	1
2002	1
2004	1
2005	1
2007	2
2008	1
2009	1
2010	4
2011	3
2013	1
2014	1
2018	1
2020	1
2021	1
2022	0

1

Can extraoral suction units minimize droplet spatter during a simulated dental procedure?

Chavis SE, Hines SE, Dyalram D, Wilken NC, Dalby RN. Chavis SE, et al. Among authors: dalby rn. J Am Dent Assoc. 2021 Feb;152(2):157-165. doi: 10.1016/j.adaj.2020.10.010. J Am Dent Assoc. 2021. PMID: 33494869 Free PMC article.

2

Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.

Ferguson GT, Dalby RN. Ferguson GT, et al. Among authors: dalby rn. Postgrad Med. 2018 Aug;130(6):515-522. doi: 10.1080/00325481.2018.1481713. Epub 2018 Jul 4. Postgrad Med. 2018. PMID: 29972656 Review.

3

Cigalike electronic nicotine delivery systems e-liquids contain variable levels of metals.

Neu HM, Lee A, Brandis JEP, Patel V, Schneider A, Kane MA, Dalby RN, Michel SLJ. Neu HM, et al. Among authors: dalby rn. Sci Rep. 2020 Jul 17;10(1):11907. doi: 10.1038/s41598-020-67789-7. Sci Rep. 2020. PMID: 32681061 Free PMC article.

4

Drug delivery to the nasal cavity: in vitro and in vivo assessment.

Newman SP, Pitcairn GR, Dalby RN. Newman SP, et al. Among authors: dalby rn. Crit Rev Ther Drug Carrier Syst. 2004;21(1):21-66. Crit Rev Ther Drug Carrier Syst. 2004. PMID: 15099184 Review.

5

Respiratory Drug Delivery Europe 2007.

Byron PR, Dalby RN, Peart J. Byron PR, et al. Among authors: dalby rn. Expert Rev Respir Med. 2007 Aug;1(1):39-41. doi: 10.1586/17476348.1.1.39. Expert Rev Respir Med. 2007. PMID: 20477264 No abstract available.

6

Phospholipid-induced in vivo particle migration to enhance pulmonary deposition.

Ganguly S, Moolchandani V, Roche JA, Shapiro PS, Somaraju S, Eddington ND, Dalby RN. Ganguly S, et al. Among authors: dalby rn. J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):343-50. doi: 10.1089/jamp.2007.0675. J Aerosol Med Pulm Drug Deliv. 2008. PMID: 18823258

7

Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders.

Dalby RN, Eicher J, Zierenberg B. Dalby RN, et al. Med Devices (Auckl). 2011;4:145-55. doi: 10.2147/MDER.S7409. Epub 2011 Sep 1. Med Devices (Auckl). 2011. PMID: 22915941 Free PMC article.

8

Automated actuation of nasal spray products: determination and comparison of adult and pediatric settings.

Doughty DV, Vibbert C, Kewalramani A, Bollinger ME, Dalby RN. Doughty DV, et al. Among authors: dalby rn. Drug Dev Ind Pharm. 2011 Mar;37(3):359-66. doi: 10.3109/03639045.2010.520321. Epub 2010 Oct 6. Drug Dev Ind Pharm. 2011. PMID: 20923391 Clinical Trial.

9

Assessment of facial and ocular deposition of nebulized aerosol using a color-based method.

Kundoor V, Dalby RN. Kundoor V, et al. Among authors: dalby rn. Drug Dev Ind Pharm. 2010 Nov;36(11):1281-5. doi: 10.3109/03639041003753854. Drug Dev Ind Pharm. 2010. PMID: 20545511

10

Use of flexible weighted nasal spray dip tubes to improve product performance.

Doughty DV, Diao L, Hoag SW, Dalby RN. Doughty DV, et al. Among authors: dalby rn. J Aerosol Med Pulm Drug Deliv. 2010 Apr;23(2):69-75. doi: 10.1089/jamp.2008.0727. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 19778208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results